The point where a laboratory build project converts steel, ductwork, and bench casework into a functioning diagnostic service is the instrument-activation phase: physically rigging analyzers into the suite, qualifying them against manufacturer and regulatory expectations, and statistically proving every assay before a single patient result can be reported. This phase sits on the critical path between substantial completion and clinical go-live, and it is governed less by the building code than by CLIA, CAP, and the analyzer vendors' own installation and qualification protocols.

This article covers the install-and-prove sequence — delivery and rigging, the IQ/OQ/PQ qualification chain, the CLIA/CAP method-verification and validation studies, and the documentation package that the lab director signs before going live. Operational workflow design and LIS/middleware build-out, the accreditation inspection itself, and chemical/biosafety commissioning are each handled in the sibling Articles of this Part.

Where instrument activation sits in the delivery timeline

Instrument activation is a distinct, vendor-and-lab-driven phase that overlaps the tail of construction commissioning and runs into clinical go-live. It cannot be compressed arbitrarily — the statistical studies have fixed minimum durations (a 20-day precision study runs 20 days regardless of schedule pressure), and they cannot begin until the room is environmentally stable and the instrument is connected to its utilities.

A typical sequence for a new or relocated core-lab line:

Stage Trigger / precondition Owner
Pre-delivery site readiness Substantial completion of the lab room; HVAC balanced and stable; utilities live GC / commissioning agent
Delivery, rigging, set-in-place Clear path of egress; floor protection; manufacturer site survey passed Rigger / vendor field service
Installation Qualification (IQ) Instrument set, leveled, connected to power/water/drain/data Vendor field service engineer (FSE)
Operational Qualification (OQ) IQ complete and signed Vendor FSE
Performance Qualification (PQ) / lab-side verification OQ complete; reagents, calibrators, QC on hand Lab technical staff
Method verification / validation Instrument performing to spec; comparison samples available Lab technical staff, signed by lab director
LIS/middleware interface validation Method studies underway Lab IT / vendor / LIS analyst
Final readiness review and go-live All studies passed and documented; director sign-off Lab director / medical director

The owner and activation team should treat the gap between "instrument powered on" and "first reportable patient result" as weeks, not days — commonly four to eight weeks for a full core-lab line, longer when method comparisons depend on outside reference labs or when the menu is broad.

Site readiness: the precondition for any qualification

No qualification protocol can start in a room that is not environmentally and dimensionally ready. Vendors issue detailed site-preparation specifications, and most require a signed pre-installation site survey before they will schedule a field engineer. The activation team confirms each of these before delivery is even scheduled:

A failed site survey is one of the most common and most expensive activation delays, because it sends an analyzer back into storage and pushes the entire downstream study chain. The project team's job is to close every site-prep item before the vendor's engineer is on a plane.

Delivery, rigging, and set-in-place

Large clinical analyzers and automation lines are heavy, oversized, and intolerant of rough handling. Set-in-place is planned as a discrete logistics event: